IDXX
IDEXX Laboratories Inc
NASDAQ: IDXX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$553.66
-2.58% today
Updated 2026-04-29
Market cap
$44.08B
P/E ratio
42.36
P/S ratio
10.24x
EPS (TTM)
$13.07
Dividend yield
—
52W range
$465 – $770
Volume
0.5M
IDEXX Laboratories Inc (IDXX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
24.60%
Operating margin
29.80%
ROE
66.20%
ROA
25.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $739.12M | $93.68M | 51.35% | 17.31% | 12.67% |
| 2007 | $922.55M | $94.01M | 50.24% | 14.76% | 10.19% |
| 2008 | $1.02B | $116.17M | 51.73% | 16.84% | 11.34% |
| 2009 | $1.03B | $122.22M | 51.01% | 17.06% | 11.85% |
| 2010 | $1.10B | $141.28M | 52.44% | 18.48% | 12.80% |
| 2011 | $1.22B | $161.79M | 53.05% | 19.38% | 13.28% |
| 2012 | $1.29B | $178.27M | 54.06% | 20.30% | 13.78% |
| 2013 | $1.38B | $187.80M | 54.91% | 19.37% | 13.64% |
| 2014 | $1.49B | $181.91M | 54.93% | 17.52% | 12.24% |
| 2015 | $1.60B | $192.08M | 55.58% | 18.72% | 11.99% |
| 2016 | $1.78B | $222.04M | 54.94% | 19.73% | 12.51% |
| 2017 | $1.97B | $263.14M | 55.73% | 20.98% | 13.36% |
| 2018 | $2.21B | $377.03M | 56.10% | 22.20% | 17.04% |
| 2019 | $2.41B | $427.72M | 56.73% | 22.97% | 17.77% |
| 2020 | $2.71B | $581.78M | 58.04% | 25.66% | 21.49% |
| 2021 | $3.22B | $744.85M | 58.76% | 28.99% | 23.17% |
| 2022 | $3.37B | $679.09M | 59.52% | 26.69% | 20.17% |
| 2023 | $3.66B | $845.04M | 59.82% | 29.97% | 23.08% |
| 2024 | $3.90B | $887.87M | 61.04% | 28.95% | 22.78% |
| 2025 | $4.30B | $1.06B | 61.80% | 31.60% | 24.62% |